(Q37861830)

English

Epigenetically-targeted therapies for the treatment of hematological malignancies

scientific article published on January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

Epigenetically-targeted therapies for the treatment of hematological malignancies (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

author name string

Georgiou E

1

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Kouidou S

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

publication date

1 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Current Medicinal Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1757-1764

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1182/BLOOD-2009-12-257261

Identifiers

10.2174/092986711795496791

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37861830&oldid=2173475808"